Treace Medical Concepts, Inc. (TMCI) shareholders
Close on Nov 17, 2026Market cap $288.75MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| John T. Treace | 12,530,959 | 19.20% | 13G (passive) amendment | Jun 30, 2026 |
| Armistice Capital, LLC Joint filing with Steven Boyd (9.79%) | 6,364,000 | 9.79% | 13G (passive) amendment | Jun 30, 2026 |
| Steven Boyd Joint filing with Armistice Capital, LLC (9.85%) | 6,364,000 | 9.85% | 13G (passive) amendment | Mar 31, 2026 |
| Neil Gagnon Joint filing with Gagnon Securities LLC (6.20%) | 6,142,107 | 9.60% | 13G (passive) amendment | Dec 31, 2025 |
| Bank Of America Corp /De/ | 3,533,774 | 5.50% | 13G (passive) | Mar 31, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of TMCI | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 6,364,000 | 9.79% | $25.33M | – | 0.31% |
| Bank Of America Corp /De/ | 3,305,100 | 5.08% | $13.15M | +90,807 | 0.00% |
| Gagnon Securities LLC | 3,029,543 | 4.66% | $12.06M | −2,172,343 | 2.32% |
| Vanguard Capital Management LLC | 2,028,479 | 3.12% | $8.07M | +566,972 | 0.00% |
| Gagnon Advisors, LLC | 1,534,034 | 2.36% | $6.11M | New | 3.88% |
| Aqr Capital Management LLC | 1,497,673 | 2.30% | $5.96M | +435,833 | 0.00% |
| BlackRock, Inc. | 1,380,021 | 2.12% | $5.49M | −1,960,002 | 0.00% |
| Marshall Wace, Llp | 1,328,592 | 2.04% | $5.29M | +1,063,659 | 0.00% |
| CIBC Bancorp USA Inc. | 1,216,044 | 1.87% | $4.84M | −2,309 | 0.01% |
| Acadian Asset Management LLC | 928,177 | 1.43% | $3.69M | −13,116 | 0.00% |
| Millennium Management LLC | 738,628 | 1.14% | $2.94M | −409,487 | 0.00% |
| Weber Capital Management LLC /Adv | 589,617 | 0.91% | $2.35M | – | 2.00% |
| D. E. Shaw & Co., Inc. | 583,277 | 0.90% | $2.32M | −257,992 | 0.00% |
| Geode Capital Management, LLC | 573,796 | 0.88% | $2.28M | −437,047 | 0.00% |
| Citadel Advisors LLC | 516,994 | 0.79% | $2.06M | −308,581 | 0.00% |
| Goldman Sachs Group Inc | 492,116 | 0.76% | $1.96M | +104,431 | 0.00% |
| Stifel Financial Corp | 435,009 | 0.67% | $1.73M | +258,917 | 0.00% |
| UBS Group AG | 366,445 | 0.56% | $1.46M | −176,460 | 0.00% |
| Jacobs Levy Equity Management, Inc | 363,729 | 0.56% | $1.45M | +99,995 | 0.01% |
| Raymond James Financial Inc | 331,110 | 0.51% | $1.32M | −26,446 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 117 | 32M | 49.0% | 31 / 38 | 32 / 30 | 5M | 10M |
| Q1 2026 | 118 | 36M | 55.3% | 32 / 34 | 29 / 25 | 11M | 7M |
| Q4 2025 | 115 | 36M | 55.1% | 31 / 30 | 35 / 35 | 8M | 12M |
| Q3 2025 | 119 | 40M | 62.2% | 15 / 44 | 34 / 21 | 5M | 3M |
| Q2 2025 | 125 | 38M | 59.1% | 19 / 48 | 41 / 30 | 4M | 4M |
| Q1 2025 | 138 | 38M | 58.4% | 30 / 41 | 45 / 26 | 5M | 4M |
| Q4 2024 | 135 | 37M | 57.6% | 25 / 42 | 47 / 23 | 3M | 7M |
| Q3 2024 | 134 | 41M | 63.0% | 29 / 35 | 50 / 21 | 12M | 7M |
| Q2 2024 | 128 | 40M | 61.7% | 38 / 55 | 25 / 41 | 12M | 20M |
| Q1 2024 | 132 | 48M | 74.2% | 19 / 48 | 47 / 14 | 9M | 6M |
| Q4 2023 | 127 | 45M | 68.4% | 32 / 47 | 37 / 28 | 18M | 13M |
| Q3 2023 | 123 | 39M | 60.3% | 24 / 63 | 30 / 38 | 8M | 10M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
96 funds held TMCI in Q1 2026, 56% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of TMCI | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 1,447,595 | 2.23% | $5.76M | 0.00% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 545,595 | 0.84% | $2.17M | 0.00% | Jun 30, 2026 |
| Vanguard Russell 2000 Index Fund | 249,411 | 0.38% | $862.96K | 0.00% | May 31, 2026 |
| Schwab U.S. Small-Cap ETF | 229,912 | 0.35% | $795.50K | 0.00% | May 31, 2026 |
| Fidelity Extended Market Index Fund | 170,911 | 0.26% | $591.35K | 0.00% | May 31, 2026 |
| iShares Micro-Cap ETF | 165,650 | 0.25% | $659.29K | 0.04% | Jun 30, 2026 |
| Vanguard Health Care Index Fund | 150,606 | 0.23% | $521.10K | 0.00% | May 31, 2026 |
| Goldman Sachs Absolute Return Tracker Fund | 102,412 | 0.16% | $407.60K | 0.01% | Jun 30, 2026 |
| Fidelity Total Market Index Fund | 87,200 | 0.13% | $301.71K | 0.00% | May 31, 2026 |
| iShares Core S&P Total U.S. Stock Market ETF | 72,379 | 0.11% | $288.07K | 0.00% | Jun 30, 2026 |
| Fidelity Series Total Market Index Fund | 72,135 | 0.11% | $249.59K | 0.00% | May 31, 2026 |
| Clearwater Select Equity Fund | 53,238 | 0.08% | $211.89K | 0.04% | Jun 30, 2026 |
| Ultra-Small Company Market Fund | 50,000 | 0.08% | $199.00K | 0.13% | Jun 30, 2026 |
| Fidelity Nasdaq Composite Index Fund | 46,975 | 0.07% | $162.53K | 0.00% | May 31, 2026 |
| Vanguard Russell 2000 Growth Index Fund | 45,333 | 0.07% | $156.85K | 0.01% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| John T. Treace | Chief Executive Officer, Director, 10% owner | 12,728,512 | 19.57% | Aug 24, 2026 |
| Sean F. Scanlan | Chief Innovation Officer | 634,656 | 0.98% | Oct 28, 2026 |
| Scot Michael Elder | Chief Legl & Comp Off, CorpSec | 753,226 | 1.16% | Oct 2, 2026 |
| Mark Hair | Chief Financial Officer | 916,100 | 1.41% | Aug 12, 2026 |
| Gaetano Guglielmino | Chief Commercial Officer | 490,901 | 0.75% | Jan 23, 2026 |
| Aaron Berutti | SVP, Sales | 205,092 | 0.32% | Aug 12, 2025 |
| Deepti Jain | Director | 100,243 | 0.15% | May 19, 2026 |
| Lawrence W. Hamilton | Director | 74,056 | 0.11% | May 19, 2026 |
| John K. Bakewell | Director | 546,356 | 0.84% | May 19, 2026 |
| Lance A. Berry | Director | 74,593 | 0.11% | May 19, 2026 |
| Betsy Hanna | Director | 75,243 | 0.12% | May 19, 2026 |
| Jane E. Kiernan | Director | 93,949 | 0.14% | May 19, 2026 |
| Richard W. Mott | Director | 1,498,111 | 2.30% | May 21, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Sean F. Scanlan Chief Innovation Officer | Oct 24, 2026 | Tax withholding | −207 | – | – | 634,656 |
| Scot Michael Elder Chief Legl & Comp Off, CorpSec | Sep 30, 2026 | Tax withholding | −25,457 | – | – | 753,226 |
| John T. Treace Chief Executive Officer, Director, 10% owner | Aug 24, 2026 | Buy | +11,000 | $4.34 | $47.74K | 7,404,383 |
| John T. Treace Chief Executive Officer, Director, 10% owner | Aug 21, 2026 | Buy | +5,000 | $4.35 | $21.75K | 7,393,383 |
| John T. Treace Chief Executive Officer, Director, 10% owner | Aug 20, 2026 | Buy | +39,944 | $4.44 | $177.35K | 7,388,383 |
| Sean F. Scanlan Chief Innovation Officer | Aug 9, 2026 | Tax withholding | −9,814 | – | – | 679,863 |
| Mark Hair Chief Financial Officer | Aug 9, 2026 | Tax withholding | −37,102 | – | – | 914,900 |
| Scot Michael Elder Chief Legl & Comp Off, CorpSec | Aug 9, 2026 | Tax withholding | −16,253 | – | – | 778,683 |
| John T. Treace Chief Executive Officer, Director, 10% owner | Jun 11, 2026 | Buy | +9,891 | $4.04 | $39.96K | 7,348,439 |
| John T. Treace Chief Executive Officer, Director, 10% owner | Jun 11, 2026 | Buy | +22,887 | $4.04 | $92.46K | 7,376,150 |
| John T. Treace Chief Executive Officer, Director, 10% owner | Jun 10, 2026 | Buy | +14,715 | $4.02 | $59.15K | 7,338,548 |
| John T. Treace Chief Executive Officer, Director, 10% owner | Jun 10, 2026 | Buy | +29,430 | $4.02 | $118.31K | 7,353,263 |
| John T. Treace Chief Executive Officer, Director, 10% owner | Jun 1, 2026 | Buy | +50,000 | $3.56 | $178.00K | 7,323,833 |
| John T. Treace Chief Executive Officer, Director, 10% owner | May 28, 2026 | Buy | +61,202 | $3.02 | $184.83K | 7,273,833 |
| John T. Treace Chief Executive Officer, Director, 10% owner | May 27, 2026 | Buy | +49,810 | $2.87 | $142.95K | 7,212,631 |
| John T. Treace Chief Executive Officer, Director, 10% owner | May 26, 2026 | Buy | +4,508 | $2.79 | $12.58K | 7,162,821 |
| Betsy Hanna Director | May 19, 2026 | Award | +30,000 | – | – | 75,243 |
| Jane E. Kiernan Director | May 19, 2026 | Award | +30,000 | – | – | 93,949 |
| Lawrence W. Hamilton Director | May 19, 2026 | Award | +30,000 | – | – | 74,056 |
| John K. Bakewell Director | May 19, 2026 | Award | +30,000 | – | – | 204,056 |
| Deepti Jain Director | May 19, 2026 | Award | +30,000 | – | – | 100,243 |
| Lance A. Berry Director | May 19, 2026 | Award | +30,000 | – | – | 74,593 |
| John T. Treace Chief Executive Officer, Director, 10% owner | May 14, 2026 | Buy | +61,750 | $2.62 | $161.79K | 7,158,313 |
| John T. Treace Chief Executive Officer, Director, 10% owner | May 13, 2026 | Buy | +49,013 | $2.46 | $120.57K | 7,096,563 |
| John T. Treace Chief Executive Officer, Director, 10% owner | May 12, 2026 | Buy | +43,000 | $2.17 | $93.31K | 7,047,550 |
| Mark Hair Chief Financial Officer | Apr 17, 2026 | Tax withholding | −11,547 | – | – | 952,002 |
| Mark Hair Chief Financial Officer | Apr 1, 2026 | Award | +100,000 | – | – | 963,549 |
| John T. Treace Chief Executive Officer, Director, 10% owner | Mar 10, 2026 | Tax withholding | −5,021 | – | – | 7,004,550 |
| Scot Michael Elder Chief Legl & Comp Off, CorpSec | Mar 10, 2026 | Tax withholding | −1,675 | – | – | 794,936 |
| Sean F. Scanlan Chief Innovation Officer | Mar 10, 2026 | Tax withholding | −1,396 | – | – | 704,677 |
| Mark Hair Chief Financial Officer | Mar 10, 2026 | Tax withholding | −3,695 | – | – | 863,549 |
| John T. Treace Chief Executive Officer, Director, 10% owner | Mar 8, 2026 | Tax withholding | −2,062 | – | – | 7,009,571 |
| Scot Michael Elder Chief Legl & Comp Off, CorpSec | Mar 8, 2026 | Tax withholding | −175 | – | – | 796,611 |
| Sean F. Scanlan Chief Innovation Officer | Mar 8, 2026 | Tax withholding | −401 | – | – | 706,073 |
| Mark Hair Chief Financial Officer | Mar 8, 2026 | Tax withholding | −964 | – | – | 867,244 |
| Sean F. Scanlan Chief Innovation Officer | Feb 10, 2026 | Option exercise | +16,875 | $1.05 | $17.72K | 706,474 |
| Mark Hair Chief Financial Officer | Jan 22, 2026 | Tax withholding | −17,037 | – | – | 493,208 |
| Mark Hair Chief Financial Officer | Jan 22, 2026 | Award | +375,000 | – | – | 868,208 |
| Sean F. Scanlan Chief Innovation Officer | Jan 22, 2026 | Award | +262,500 | – | – | 689,599 |
| John T. Treace Chief Executive Officer, Director, 10% owner | Jan 22, 2026 | Award | +250,000 | – | – | 7,011,633 |
| John T. Treace Chief Executive Officer, Director, 10% owner | Jan 22, 2026 | Tax withholding | −14,254 | – | – | 6,761,633 |
| Gaetano Guglielmino Chief Commercial Officer | Jan 22, 2026 | Award | +150,000 | – | – | 490,901 |
| Scot Michael Elder Chief Legl & Comp Off, CorpSec | Jan 22, 2026 | Award | +262,500 | – | – | 796,786 |
| Scot Michael Elder Chief Legl & Comp Off, CorpSec | Jan 22, 2026 | Tax withholding | −9,451 | – | – | 534,286 |
| Sean F. Scanlan Chief Innovation Officer | Jan 21, 2026 | Option exercise | +53,500 | $0.72 | $38.52K | 427,099 |
| Mark Hair Chief Financial Officer | Jan 10, 2026 | Tax withholding | −8,719 | – | – | 510,245 |
| John T. Treace Chief Executive Officer, Director, 10% owner | Jan 10, 2026 | Tax withholding | −13,219 | – | – | 6,775,887 |
| Scot Michael Elder Chief Legl & Comp Off, CorpSec | Jan 10, 2026 | Tax withholding | −4,544 | – | – | 543,737 |
| Gaetano Guglielmino Chief Commercial Officer | Dec 1, 2025 | Tax withholding | −20,090 | – | – | 342,910 |
| Gaetano Guglielmino Chief Commercial Officer | Dec 1, 2025 | Tax withholding | −2,009 | – | – | 340,901 |
| Scot Michael Elder Chief Legl & Comp Off, CorpSec | Oct 25, 2025 | Tax withholding | −984 | – | – | 548,281 |
| Sean F. Scanlan Chief Innovation Officer | Oct 24, 2025 | Tax withholding | −208 | – | – | 373,599 |
| Scot Michael Elder Chief Legl & Comp Off, CorpSec | Oct 2, 2025 | Tax withholding | −650 | – | – | 549,265 |
| Scot Michael Elder Chief Legl & Comp Off, CorpSec | Sep 30, 2025 | Tax withholding | −16,234 | – | – | 549,915 |
| Sean F. Scanlan Chief Innovation Officer | Aug 9, 2025 | Tax withholding | −9,814 | – | – | 373,807 |
| Aaron Berutti SVP, Sales | Aug 9, 2025 | Tax withholding | −4,907 | – | – | 205,092 |
| Scot Michael Elder Chief Legl & Comp Off, CorpSec | Aug 9, 2025 | Tax withholding | −10,515 | – | – | 566,149 |
| Mark Hair Chief Financial Officer | Aug 9, 2025 | Tax withholding | −22,212 | – | – | 518,964 |
| Sean F. Scanlan Chief Innovation Officer | Jul 18, 2025 | Option exercise | +33,437 | $0.72 | $24.07K | 383,621 |
| Lawrence W. Hamilton Director | May 20, 2025 | Award | +23,917 | – | – | 44,056 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Treace Medical Concepts's stock actually held short. Settlement fails (shares not delivered on time) peaked at 16,020 shares on Oct 6, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Sean F. Scanlan Officer | Mar 17, 2025 | 50,000 | $397.50K | Mar 17, 2025 | Exercise of Stock Options |
| Timbie Thomas E Director | Jun 14, 2023 | 24,266 | $618.72K | Jun 14, 2023 | STOCK OPTION EXERCISE |
| F. Barry Bays Other: Former Board Member | Jun 5, 2023 | 1,042,318 | $27.63M | Jun 5, 2023 | Acquired from issuer in private transaction |
| F. Barry Bays Other: Former Board Member | Jun 2, 2023 | 47,923 | $1.27M | Jun 2, 2023 | Acquired from issuer in private transaction |
| James T. Treace Director | May 1, 2023 | 10,000 | $252.02K | May 1, 2023 | Private placement |
| F. Barry Bays Other: Board Member | Apr 26, 2023 | 40,000 | $1.02M | Apr 26, 2023 | Acquired from issuer in private transaction |
| F. Barry Bays Revocable Trust U/A 11/11/14 Board Member | Apr 11, 2023 | 100,000 | $2.63M | Apr 11, 2023 | Acquired from issuer in private transaction |
See a number that looks wrong?